Viridian Therapeutics, Inc.\DE Annual Nonoperating Income (Expense) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Viridian Therapeutics, Inc.\DE quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to 2023.
  • Viridian Therapeutics, Inc.\DE Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $7.19M, a 70.8% increase year-over-year.
  • Viridian Therapeutics, Inc.\DE Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $22.7M, a 79.1% increase year-over-year.
  • Viridian Therapeutics, Inc.\DE annual Nonoperating Income (Expense) for 2023 was $16.7M, a 277% increase from 2022.
  • Viridian Therapeutics, Inc.\DE annual Nonoperating Income (Expense) for 2022 was $4.43M, a 1306% increase from 2021.
  • Viridian Therapeutics, Inc.\DE annual Nonoperating Income (Expense) for 2021 was $315K, a 82.1% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $16.7M +$12.3M +277% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $4.43M +$4.12M +1306% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $315K +$142K +82.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $173K -$768K -81.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $941K -$313K -25% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-26
2018 $1.25M +$851K +211% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 $403K +$364K +933% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
2016 $39K Jan 1, 2016 Dec 31, 2016 10-K 2018-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.